Endocrine, Metabolic & Immune Disorders - Drug Targets

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back Subscribe
Case Report

A Case Report of Anti-GAD65 Antibody-Positive Autoimmune Encephalitis Associated with Diabetes

In Press. Available online December 04, 2025
Author(s): Xiuping Xuan, Liheng Meng, Lulu Chen, Xuemei Xie, Xinghuan Liang* and Yingfen Qin*
Published on: 04 December, 2025

Article ID: e18715303405229

DOI: 10.2174/0118715303405229251028051625

open_access

Become a Editorial Board Member
Become a Reviewer
Become a Editor
Become a Section Editor

Abstract

Background: Patients with GAD65 antibody-associated autoimmune encephalitis who also have diabetes are usually considered to have type 1 diabetes mellitus (T1DM). However, previous reports often lacked β-cell function assessments, relying solely on anti-GAD65 positivity for diagnosis, which is insufficient for accurate classification.

Case presentation: We present a 30-year-old Chinese woman diagnosed with GAD65-associated autoimmune encephalitis, hyperthyroidism, and diabetes. Her peak C-peptide level was 3.99 ng/mL, inconsistent with the β-cell dysfunction typical of classic T1DM. The combination of high GAD65 antibody titers and preserved β-cell function made it challenging to determine her diabetes type.

Conclusion: This case suggests that clinicians should pay more attention to assessing and monitoring β-cell function when GAD65-associated autoimmune encephalitis is accompanied by diabetes.

Keywords: Glutamate decarboxylase 65, autoimmune encephalitis, diabetes, β cell function.